Phase II study of the halichondrin B analog eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline, a taxane, and capecitabine

1. Cortes, J.
2. Vahdat, L.
3. Blum, J.L.
4. Twelves, C.
5. Campone, M.
6. Roché, H.
7. Bachelot, T.
8. Awada, A.
9. Paridaens, R.
10. Goncalves, A.
11. Shuster, D.E.
12. Wanders, J.
13. Fang, F.
14. Gurnani, R.
15. Richmond, E.
16. Cole, P.E.
17. Ashworth, S.
18. Allison, M.A.